Page last updated: 2024-09-04

beta-lactams and Urinary Tract Infections

beta-lactams has been researched along with Urinary Tract Infections in 137 studies

Research

Studies (137)

Timeframe	Studies, this research(%)	All Research%
pre-1990	14 (10.22)	18.7374
1990's	3 (2.19)	18.2507
2000's	41 (29.93)	29.6817
2010's	62 (45.26)	24.3611
2020's	17 (12.41)	2.80

Authors

Authors	Studies
Cai, Y; Jia, Y; Wang, J; Yan, K; Zhu, M	1
Huang, HY; Lin, YC; Lu, PL; Tang, YH	1
Aronin, SI; Dunne, MW; Gupta, V; Watts, JA; Yu, KC	1
Martín-Jiménez, T; Martinez, MN; Miller, RA; Sharkey, MJ	1
Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L	1
Das, AK; Dudeja, M; Kohli, S; Ray, P	1
Acosta, D; Benning, M; Sarangarm, P; Walraven, C	1
Chen, L; He, XP; Hong, SJ; Hua, J; Jing, RC; Luo, XY; Xue, HW; Yuan, CY; Yue, Y	1
Hasani, A; Nahandi, MZ; Nejad, MK; Soofiyani, SR	1
Higuita-Gutiérrez, LF; Jiménez-Quiceno, JN; Vargas-Alzate, CA	1
Cobian, J; Hall, B; Miller, J; Wilson, K	1
Chang, SP; Hung, SH; Lai, CC; Lan, SH; Lin, WT; Lu, LC	1
Antsupova, V; Arpi, M; Boel, JB; Holzknecht, BJ; Jarløv, JO; Knudsen, JD	1
Chang, NN; Khader, K; Spivak, ES; Stevens, VW; Sutton, JD; Timbrook, TT	1
Afra, K; Lee, C; Mina, N; Saad, S	1
Fink, G; Horn, S; Kern, WV	1
Gibble, A; Huang, A; Sapozhnikov, J; Zeeck, K	1
Bader, M; Seitz, M; Stief, C; Tilki, D; Waidelich, R	1
Tamma, PD; Villegas, MV	1
Kim, HS; Kim, HY; Kim, YK; Lee, J; Lee, JA; Lee, SS; Seo, YB; Song, W; Uh, Y	1
Klevišar, MN; Lusa, L; Pirš, M; Premru, MM; Strle, F; Stupica, D; Terzić, S	1
Fujiya, Y; Hayakawa, K; Kutsuna, S; Mawatari, M; Ohmagari, N; Takeshita, N; Yamamoto, K	1
Monogue, ML; Nicolau, DP	1
Grant, M; Holt, S; Thompson-Brazill, KA	1
Cassisa, V; Chenouard, R; Eveillard, M; Kempf, M; Lemarié, C; Pailhoriès, H	1
Achard, MES; Anderson, GJ; Djoko, KY; Hancock, SJ; Harris, PN; Lo, AW; McEwan, AG; Miraula, M; Mitić, N; Paterson, DL; Peters, KM; Phan, MD; Prombhul, S; Schembri, MA; Schenk, G; Shafer, WM; Sidjabat, HE; Walsh, TR	1
Chu, CM; Lowder, JL	1
Forstner, C; Pletz, MW; Wagenlehner, F; Weis, S	2
Chen, M; Deng, Y; Huang, P; Lin, Q; Sun, C; Zeng, H; Zhang, M	1
Davis, SL; Herc, ES; Mercuro, NJ; Zervos, MJ	1
Alessio, P; Cimino, S; Imbimbo, C; Migliara, A; Mirone, V; Morgia, G; Russo, GI; Venturino, L; Verze, P	1
Badal, R; Duan, Q; Gui, B; Huang, W; Jiang, X; Kong, H; Li, H; Liao, K; Ni, Y; Shan, B; Sun, Z; Wang, W; Wang, Y; Wu, A; Xu, Y; Yang, C; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Naber, KG; Wagenlehner, FME	1
Courter, J; DeBurger, B; Forster, CS; Haslam, DB; Mortensen, JE; Powell, EA	1
Barrios-Arnau, L; Di Capua-Sacoto, C; Gomila Sard, B; Ponce-Blasco, P; Rodrigo-Aliaga, M; Sanchez-Llopis, A	1
Baziaka, F; Galani, L; Giamarellou, H; Karaiskos, I	1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ	1
Araque, M; Mendoza, E; Millán, B; Salas, M	1
Chang, CL; Chang, KK; Huang, YC; Lu, CM; Su, LH; Tai, FT	1
Beardsley, JR; Johnson, JW; Koliscak, LP; Luther, VP; Miller, DP; Ohl, CA; Williamson, JC	1
Bastide, C; Bernard, L; Bruyère, F; Chaussade, H; Coloby, P; Guy, L; Karsenty, G; Sunder, S	1
Bai, N; Cai, Y; Liang, B; Liu, Y; Sun, C; Wang, J; Wang, R; Zhang, L	1
Esteban Fernández, J; Padilla Peinado, R; Rodríguez Álvarez, S; Villa Albuguer, T	1
Bowman, C; Charlett, A; Cookson, B; Davey, P; Fleet, E; Gopal Rao, G; Patel, B	1
Fisher, DA; Hee, KH; Lee, LS; Llorin, RM; Lye, DC; Sulaiman, Z; Tam, VH; Zhou, J	1
Chang, SC; Chen, PC; Huang, IW; Lai, JF; Lauderdale, TL; Shiau, YR; Tan, MC; Wang, HY; Wang, JT	1
Chang, FY; Chiu, CH; Lin, DY; Lin, HA; Lin, HC; Lin, JC; Wang, JX; Yang, YS; Yeh, KM	1
Eslami, G; Langaee, T; Rafati, M; Rafiei, A; Rezai, MS; Salehifar, E; Shafahi, K	1
Cprek, JB; Gallagher, JC	1
Ayaz, T; Kara, E; Sahin, OZ; Sahutoglu, T; Tufekci, A; Yildirim, S	1
Al Atya, AK; Drider, D; Drider-Hadiouche, K; Vachee, A	1
Jeon, YL; Kang, SY; Kim, MH; Lee, MY; Lee, WI	1
Cunha, BA; Gerson, S; Giuga, J	1
Davis, SL; Grunwald, JL; Kenney, RM; Veve, MP; Wagner, JL	1
Archuleta, S; Chan, M; Fisher, DA; Llorin, RM; Lye, DC; Sulaiman, Z; Tam, VH; Tan, SY; Trad, MA; Zhong, LH	1
Manzano-García, M; Márquez-Saavedra, E	1
Borgia, G; Gentile, I; Maraolo, AE	1
Hsueh, PR; Jean, SS	1
Bader, MS; Brooks, AA; Loeb, M	1
Boroumandi, S; Ghafoori, SM; Heidari, H; Houri, H; Kazemian, H; Tayebi, Z	1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF	1
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P	1
Jitmuang, A; Kiratisin, P; Rattanaumpawan, P; Thamlikitkul, V; Werarak, P	1
Arguedas, A; Blumer, J; Botet, FA; Cespedes, J; Gesser, R; Snyder, T; Wang, J; West, J; Wimmer, W; Yogev, R	1
Chan, J; Leo, YS; Lye, DC; Teng, CP; Wijaya, L	1
Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL	1
Lortholary, O; Martin, C; Nordmann, P; Plesiat, P; Potel, G; Zahar, JR	1
Amicosante, G; Celenza, G; Forcella, C; Frascaria, P; Pellegrini, C; Perilli, M; Segatore, B	1
Abe, T; Azagami, S; Bamba, M; Cho, H; Hojo, H; Jozaki, K; Koizumi, Y; Nakao, A; Nonoyama, M; Ojima, T; Ozaki, A; Sunakawa, K; Yokota, T	1
Khokhlova, OI; Ust'iantseva, IM; Zakharova, GV; Zhevlakova, IuA	1
Childs, S; Colgan, R; Gomolin, IH; Gould, M; Gupta, K; Hooton, TM	2
Ablij, HC; Assendelft, WJ; Blom, JW; Delfos, NM; Elzevier, HW; Koster, T; Kuijper, EJ; Leyten, EM; Pander, J; Spelt, IC; van Dissel, JT; van Nieuwkoop, C; van't Wout, JW; Wattel-Louis, GH	1
Lee, CH; Lin, WC; Liu, JW; Su, LH; Tang, YF	1
Aihara, Y; Harada, T; Ito, S; Machida, H; Teranishi, J; Yokota, S	1
Pilla, V; Qi, C; Reed, K; Yu, JH	1
Akata, F; Celik, AD; Eroglu, C; Kuloglu, F; Torol, S; Vahaboğlu, H; Yulugkural, Z	1
Bazaz, R; Chapman, AL; Winstanley, TG	1
Green, H; Leibovici, L; Paul, M; Yaphe, J; Zalmanovici Trestioreanu, A	1
Corona, D; Gona, F; Mezzatesta, ML; Scriffignano, V; Stefani, S; Veroux, M; Veroux, P; Zerbo, D	1
Bayraktar, B; Dalgic, N; Dincer, E; Pelit, S; Sancar, M	1
Amyes, SG; Dancer, SJ; Findlay, J; Hamouda, A	1
Iakovlev, AA; Kolbin, AS; Musatov, VB; Sidorenko, SV; Zagorodnikova, KA	1
Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E	1
Chiu, CH; Su, LH; Wu, TL	1
Chung, MH; Kim, HY; Kim, JY; Kim, MJ; Lee, JS; Lee, MS; Park, DW; Park, YS; Peck, KR; Yeom, JS	1
Bitterman, H; Denekamp, Y; Kochavi, T; Vardi, M	1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW	1
Burdmann, EA; Gesser, RM; Jiang, Q; Reyna, OG; Tomera, KM; Wimmer, WM; Woods, GL	1
Berthel, M; Heitz, D; Jehl, F; Kaltenbach, G; Kiesmann, M; Kuntzmann, F; Martin-Hunyadi, C; Noblet-Dick, M; Vogel, T	1
Amicosante, G; Colì, A; Docquier, JD; Lombardi, G; Luzzaro, F; Perilli, M; Riccio, ML; Rossolini, GM; Toniolo, A	1
Fujimoto, N; Iihara, K; Inatomi, H; Kobayashi, T; Matsumoto, T; Muratani, T; Nishimura, T; Takahashi, K; Yamada, Y	1
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL	1
Cisowska, A; Doroszkiewicz, W; Jankowski, S; Korzekwa, K; Lewczyk, E; Wojnicz, D	1
Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M	1
Alhambra, A; Alós, JI; Cacho, J; Cuadros, JA; Gómez-Garcés, JL	1
Gesser, RM; Jiang, Q; Wells, WG; Woods, GL	1
Cui, WL; Li, WL; Wang, LX; Xu, DX	1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W	1
Nickel, JC	1
Dzierzanowska, D; Kamińska, W	1
Arpin, C; Brochet, JP; Dubois, V; Dutilh, B; Fischer, I; Jullin, J; Larribet, G; Maugein, J; Quentin, C	1
Calbo, E; Garau, J; Gómez, L; Quintana, S; Romaní, V; Vidal, CG; Vila, J; Xercavins, M	1
Borer, A; Riesenberg, K; Saidel-Odes, L; Schlaeffer, F; Smolyakov, R	1
Arrigucci, S; Cassetta, MI; Fallani, S; Mazzei, T; Novelli, A	1
Fariñas, MC; García-Palomo, D; Horcajada, JP	1
Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK	1
Burkhardt, O; Derendorf, H; Welte, T	1
Cubells, CL; García-García, JJ; Giralt, AG; Magín, EC; Sert, SZ	1
Cantón, R; de la Maza, OM; de la Pedrosa, EG; Martín, O; Morosini, MI	1
Botto, H; Bourg, G; Combescure, C; Lavigne, JP; Sotto, A	1
Ip, M; Kei, HW; Lau, WC; Lee, N; Marasinghe, T; Wong, KY; You, JH	1
Ariza, J; Calatayud, L; Domínguez, MA; Gudiol, C; Gudiol, F; Peña, C; Pujol, M; Tubau, F	1
Hiraga, N; Matsumoto, T; Muratani, T; Naito, S	1
Ball, AP; Brookes, GR; Davey, PG; Farrell, ID; Geddes, AM	1
Esposito, S; Martinelli, R; Scioli, C	1
Fugono, T; Imada, A; Kondo, M; Nakao, M; Nishi, T; Tsuchiya, K	1
Bradnock, K; Leigh, DA; Marriner, JM	1
Celliers, D; Du Plessis, DJ; Lindeque, KP; Van Rensburg, AJ	1
Ahrens, T; Maly, V; Naber, K; Puppel, H; Schultheis, H; Zimmermann, W	1
Avery, GS; Brogden, RN; Carmine, A; Heel, RC; Morley, PA; Speight, TM	1
Kienitz, M	1
Arata, J; Moritono, S; Saito, A	1
Beach, ML; Doern, GV; Gales, AC; Gordon, KA; Jones, RN; Pfaller, MA; Sader, HS; Wilke, WW	1
Caniça, M; Correia, JD; Féria, C; Ferreira, E; Gonçalves, J	1
Cajigas, J; Gesser, RM; Imbeault, D; Jasovich, A; Jiang, Q; Jimenez-Cruz, F; Woods, GL	1
Acar, JF; Goldstein, FW; Kitzis, MD	1
Abraham, SN; Baddour, LM; Christensen, GD; Hasty, DL; Josephs, JA; Lowrance, JH; Madison, BM; Parisi, JT; Simpson, WA	1
Borderon, E; Desroche, A; Du Rouchet, E; Lemaire, B; Megier, P; Tescher, M	1
DeJace, P; Klastersky, J	1
Daikos, GL; Jackson, GG; Kathpalia, SB; Lolans, VT; Sharifi, R	1
Barba, D; Esposito, S; Galante, D	1
Rozhavin, MA; Rudenko, AV	1
Brooks, HL; Gargan, R; Greenwood, D; O'Grady, F	1

Reviews

21 review(s) available for beta-lactams and Urinary Tract Infections

Article	Year
Efficacy and safety of quinolones vs. other antimicrobials for the treatment of uncomplicated urinary tract infections in adults: a systematic review and meta-analysis. International urogynecology journal, 2022, Volume: 33, Issue:5 Topics: Adult; Anti-Infective Agents; beta-Lactams; Fosfomycin; Humans; Nitrofurantoin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2022
Application of pharmacokinetic/pharmacodynamic concepts to the development of treatment regimens for sporadic canine urinary tract infections: Challenges and paths forward. Journal of veterinary pharmacology and therapeutics, 2022, Volume: 45, Issue:5 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Dog Diseases; Dogs; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Urinary Tract Infections	2022
Aptitude of Uropathogenic Escherichia coli in Renal Transplant Recipients: A Comprehensive Review on Characteristic Features, and Production of Extended Spectrum β-Lactamase. Current microbiology, 2023, Oct-21, Volume: 80, Issue:12 Topics: Anti-Bacterial Agents; Aptitude; beta-Lactamases; beta-Lactams; Escherichia coli Infections; Humans; Kidney Transplantation; Urinary Tract Infections; Uropathogenic Escherichia coli	2023
Novel β-Lactam/β-Lactamase inhibitor combinations vs alternative antibiotics in the treatment of complicated urinary tract infections: A meta-analysis of randomized controlled trials. Medicine, 2020, Volume: 99, Issue:19 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Humans; Pyelonephritis; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Tract Infections	2020
Diagnosis and treatment of urinary tract infections across age groups. American journal of obstetrics and gynecology, 2018, Volume: 219, Issue:1 Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Asymptomatic Infections; Bacteriuria; beta-Lactams; Culture Techniques; Drug Resistance, Bacterial; Female; Fluoroquinolones; Fosfomycin; Humans; Lower Urinary Tract Symptoms; Middle Aged; Nitrites; Nitrofurantoin; Pregnancy; Pregnancy Complications, Infectious; Pyuria; Trimethoprim, Sulfamethoxazole Drug Combination; Urinalysis; Urinary Tract Infections	2018
Novel β-lactam/β-lactamase inhibitors versus alternative antibiotics for the treatment of complicated intra-abdominal infection and complicated urinary tract infection: a meta-analysis of randomized controlled trials. Expert review of anti-infective therapy, 2018, Volume: 16, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Humans; Intraabdominal Infections; Randomized Controlled Trials as Topic; Urinary Tract Infections	2018
Combatting resistant enterococcal infections: a pharmacotherapy review. Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:9 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Urinary Tract Infections	2018
[Antibiotic treatments in urology]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23, Issue:15 Topics: Anti-Bacterial Agents; beta-Lactams; Fosfomycin; Glycopeptides; Humans; Nitrofurans; Paromomycin; Quinolones; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2013
Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials. Chinese medical journal, 2014, Volume: 127, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Ertapenem; Humans; Intraabdominal Infections; Pneumonia; Randomized Controlled Trials as Topic; Urinary Tract Infections	2014
An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgraduate medicine, 2017, Volume: 129, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Comorbidity; Drug Resistance, Bacterial; Fluoroquinolones; Fosfomycin; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Minocycline; Nitrofurantoin; Severity of Illness Index; Urinary Tract Infections	2017
Addressing the challenge of extended-spectrum beta-lactamases. Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Urinary Tract Infections	2009
Urinary tract infections. Current approaches, future directions. Postgraduate medicine, 2000, Volume: 108, Issue:7 Suppl Pr Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacterial Infections; beta-Lactams; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Pregnancy; Prevalence; Recurrence; Sex Factors; Urinary Tract Infections	2000
Antimicrobial agents for treating uncomplicated urinary tract infection in women. The Cochrane database of systematic reviews, 2010, Oct-06, Issue:10 Topics: Acute Disease; Anti-Infective Agents; Anti-Infective Agents, Urinary; beta-Lactams; Female; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2010
Appropriate use of the carbapenems. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections	2004
[Antimicrobial drug resistant pathogens in nosocomial urinary tract infections--selected aspects]. Polskie Archiwum Medycyny Wewnetrznej, 2004, Volume: 112 Spec No Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Humans; Infection Control; Poland; Risk Factors; Urinary Tract Infections	2004
[Treatment of uncomplicated lower urinary tract infections]. Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23 Suppl 4 Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fosfomycin; Humans; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2005
[Ertapenem and other antibacterials]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Clinical Trials as Topic; Drug Evaluation, Preclinical; Ertapenem; Female; Genital Diseases, Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pregnancy; Skin Diseases, Infectious; Urinary Tract Infections	2006
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Drug Interactions; Drug Resistance, Bacterial; Endometritis; Ertapenem; Female; Humans; Peritonitis; Protein Binding; Renal Insufficiency; Surgical Wound Infection; Urinary Tract Infections	2007
IRT and CMT beta-lactamases and inhibitor resistance. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 1 Topics: Amino Acid Substitution; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Urinary Tract Infections	2008
Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs, 1981, Volume: 22, Issue:5 Topics: Amoxicillin; Animals; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Half-Life; Humans; Intestinal Absorption; Mice; Respiratory Tract Infections; Sexually Transmitted Diseases; Tissue Distribution; Urinary Tract Infections	1981
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cellulitis; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Pneumonia; Pseudomonas Infections; Sepsis; Urinary Tract Infections	1986

Trials

15 trial(s) available for beta-lactams and Urinary Tract Infections

Article	Year
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli. BMC infectious diseases, 2017, 06-07, Volume: 17, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Republic of Korea; Tazobactam; Urinary Tract Infections	2017
Impact of implementation of a novel antimicrobial stewardship tool on antibiotic use in nursing homes: a prospective cluster randomized control pilot study. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Female; Humans; Inappropriate Prescribing; Long-Term Care; Male; Nursing Homes; Pilot Projects; Practice Patterns, Physicians'; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections; Urinary Tract Infections	2014
Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial. BMC infectious diseases, 2017, 03-01, Volume: 17, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections	2017
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection. International journal of antimicrobial agents, 2009, Volume: 33, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Infant; Male; Molecular Sequence Data; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections	2009
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days). BMC infectious diseases, 2009, Aug-19, Volume: 9 Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Double-Blind Method; Female; Fever; Gentamicins; Humans; Male; Urinary Tract Infections	2009
Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial. Journal of Korean medical science, 2012, Volume: 27, Issue:5 Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Double-Blind Method; Ertapenem; Humans; Odds Ratio; Pyelonephritis; Republic of Korea; Risk Factors; Urinary Tract Infections	2012
Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Prospective Studies; Urinary Tract Infections	2002
[Faropenem 300 mg 3 times daily versus levofloxacin 100 mg 3 times daily in the treatment of urinary tract infections in patients with neurogenic bladder and/or benign prostatic hypertrophy]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2002, Volume: 76, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Drug Administration Schedule; Female; Humans; Lactams; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatic Hyperplasia; Urinary Bladder, Neurogenic; Urinary Tract Infections	2002
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:5 Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections	2003
Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Double-Blind Method; Drug Administration Schedule; Ertapenem; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Lactams; Male; Middle Aged; Multicenter Studies as Topic; Pyelonephritis; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Tract Infections	2004
In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:4 Topics: Adult; Animals; Bacterial Adhesion; beta-Lactam Resistance; beta-Lactams; Caenorhabditis elegans; Capsules; Cell Line; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Epithelial Cells; Escherichia coli; Escherichia coli Infections; Female; Humans; Treatment Outcome; Urinary Tract Infections; Vaccinium macrocarpon	2008
Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study. Lancet (London, England), 1980, Mar-22, Volume: 1, Issue:8169 Topics: Administration, Oral; Amoxicillin; Bacteriuria; beta-Lactamase Inhibitors; beta-Lactams; Biological Products; Carboxylic Acids; Clavulanic Acid; Clinical Trials as Topic; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Streptomyces; Tablets; Urinary Tract Infections	1980
A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults. Urology, 2002, Volume: 60, Issue:1 Topics: Administration, Oral; Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Prospective Studies; Treatment Outcome; Urinary Tract Infections	2002
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cellulitis; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Pneumonia; Pseudomonas Infections; Sepsis; Urinary Tract Infections	1986
Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora. The American journal of medicine, 1987, Apr-27, Volume: 82, Issue:4A Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Feces; Female; Gram-Negative Aerobic Bacteria; Humans; Intestines; Male; Middle Aged; Urinary Tract Infections	1987

Other Studies

102 other study(ies) available for beta-lactams and Urinary Tract Infections

Article	Year
Clinical effectiveness of beta-lactams versus fluoroquinolones as empirical therapy in patients with diabetes mellitus hospitalized for urinary tract infections: A retrospective cohort study. PloS one, 2022, Volume: 17, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Diabetes Mellitus, Type 2; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome; Urinary Tract Infections	2022
Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018-2020. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 119 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections	2022
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France. Infectious diseases now, 2022, Volume: 52, Issue:7 Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections	2022
Genotypic characterization of vancomycin-resistant The Indian journal of medical research, 2022, Volume: 155, Issue:3&4 Topics: Anti-Bacterial Agents; beta-Lactams; Cross-Sectional Studies; Erythromycin; Fluoroquinolones; Genotype; Gentamicins; Humans; Linezolid; Pristinamycin; Teicoplanin; Tigecycline; Urinary Tract Infections; Vancomycin; Vancomycin-Resistant Enterococci	2022
Revisiting β-Lactams for Treatment of Urinary Tract Infections: Assessing Clinical Outcomes of Twice-Daily Cephalexin for Empiric Treatment of Uncomplicated Urinary Tract Infections. Journal of clinical pharmacology, 2023, Volume: 63, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Cephalexin; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Retrospective Studies; Urinary Tract Infections	2023
Comparison of the relative efficacy of β-lactam/β-lactamase inhibitors and carbapenems in the treatment of complicated urinary tract infections caused by ceftriaxone-non-susceptible Enterobacterales: a multicentre retrospective observational cohort study. The Journal of antimicrobial chemotherapy, 2023, 03-02, Volume: 78, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Lactams; Retrospective Studies; Urinary Tract Infections	2023
Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia Biomedica : revista del Instituto Nacional de Salud, 2019, 05-01, Volume: 39, Issue:s1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; Cohort Studies; Colombia; Cross Infection; Diagnostic Imaging; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Health Expenditures; Hospitalization; Hospitals, Urban; Humans; Male; Middle Aged; Tertiary Care Centers; Urinary Tract Infections	2019
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department. The American journal of emergency medicine, 2020, Volume: 38, Issue:12 Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medicaid Services, U.S.; Early Diagnosis; Early Medical Intervention; Emergency Service, Hospital; Female; Guideline Adherence; Hospital Mortality; Hospitalization; Humans; Male; Medical Overuse; Meropenem; Middle Aged; Patient Care Bundles; Piperacillin, Tazobactam Drug Combination; Reimbursement Mechanisms; Retrospective Studies; Sepsis; Shock, Septic; Soft Tissue Infections; Time-to-Treatment; United States; Urinary Tract Infections; Vancomycin	2020
Intravenous mecillinam compared with other β-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus. The Journal of antimicrobial chemotherapy, 2021, 01-01, Volume: 76, Issue:1 Topics: Amdinocillin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract; Urinary Tract Infections	2021
Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source. JAMA network open, 2020, 10-01, Volume: 3, Issue:10 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Cohort Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2020
Oral beta-lactam step down in bacteremic E. coli urinary tract infections. BMC infectious diseases, 2020, Oct-21, Volume: 20, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Blood Culture; Clostridioides difficile; Clostridium Infections; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections	2020
[Antibiotic stewardship - recent developments]. Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:24 Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Cephalosporins; Fluoroquinolones; Germany; Humans; Neutropenia; Piperacillin, Tazobactam Drug Combination; Urinary Tract Infections	2020
Comparison of outcomes in urinary tract infections caused by AmpC-harboring organisms treated with AmpC stable versus AmpC susceptible agents. Diagnostic microbiology and infectious disease, 2021, Volume: 101, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections	2021
Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem. World journal of urology, 2017, Volume: 35, Issue:11 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy, Large-Core Needle; Ciprofloxacin; Endosonography; Ertapenem; Humans; Image-Guided Biopsy; Male; Middle Aged; Prostate; Retrospective Studies; Surgical Wound Infection; Urinary Tract Infections	2017
Use of β-Lactam/β-Lactamase Inhibitors for Extended-Spectrum-β-Lactamase Infections: Defining the Right Patient Population. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Catheter-Related Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Propensity Score; Urinary Tract Infections	2017
Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis? International journal of antimicrobial agents, 2017, Volume: 50, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Male; Retrospective Studies; Urinary Tract Infections	2017
Bacteraemic urinary tract infections in a tertiary hospital in Japan: the epidemiology of community-acquired infections and the role of non-carbapenem therapy. BMC research notes, 2017, Jul-27, Volume: 10, Issue:1 Topics: Bacteremia; beta-Lactams; Enterobacteriaceae; Humans; Japan; Tertiary Care Centers; Urinary Tract Infections	2017
Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Disease Models, Animal; Ertapenem; Escherichia coli Infections; Female; Humans; Levofloxacin; Mice, Inbred ICR; Microbial Sensitivity Tests; Urinary Tract Infections; Uropathogenic Escherichia coli	2017
Reducing Carbapenem Exposure: Extended-Spectrum β-Lactamase Catheter-Associated Urinary Tract Infection Management. Critical care nurse, 2017, Volume: 37, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Enterobacteriaceae; Female; Humans; Male; Middle Aged; United States; Urinary Tract Infections	2017
Staphylococcus saprophyticus: Which beta-lactam? International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 65 Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cystitis; Drug Resistance, Multiple, Bacterial; Empirical Research; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyelonephritis; Staphylococcus saprophyticus; Urinary Tract Infections; Young Adult	2017
Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2 Topics: Adjuvants, Pharmaceutic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Coordination Complexes; Copper; Ertapenem; Escherichia coli; Humans; Ions; Meropenem; Microbial Sensitivity Tests; Urinary Tract Infections	2018
[Urosepsis]. Der Urologe. Ausg. A, 2018, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections	2018
[Urosepsis]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2018, Volume: 113, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections	2018
Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis. European urology focus, 2020, 03-15, Volume: 6, Issue:2 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cohort Studies; Fluoroquinolones; Fosfomycin; Humans; Image-Guided Biopsy; Male; Middle Aged; Propensity Score; Prostate; Urinary Tract Infections	2020
Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China. BMC infectious diseases, 2018, Sep-29, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; China; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Urinary Tract Infections	2018
Novel Antibiotics in the Treatment of Urinary Tract Infections. European urology focus, 2019, Volume: 5, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cystitis; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Iatrogenic Disease; Tetracyclines; Urinary Tract Infections	2019
Association of systemic antimicrobials with the expression of beta-lactamases in bacteria cultured from urological patients. Diagnostic microbiology and infectious disease, 2019, Volume: 94, Issue:4 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple, Bacterial; Electronic Health Records; Gram-Negative Bacteria; Humans; Infant; Microbial Sensitivity Tests; Urinary Tract Infections; Young Adult	2019
[Extended spectrum beta-lactamase producing Escherichia coli in a tertiary hospital. Is there an increase of resistances to beta lactams?] Archivos espanoles de urologia, 2019, Volume: 72, Issue:6 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Retrospective Studies; Tertiary Care Centers; Urinary Tract Infections	2019
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome; Urinary Tract Infections	2013
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011. Clinical therapeutics, 2013, Volume: 35, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Female; Gram-Negative Bacteria; Humans; Imipenem; Inpatients; Male; United States; Urinary Tract Infections	2013
CTX-M-32 beta-lactamase-producing uropathogenic Escherichia coli isolated in Latin America. Journal of infection in developing countries, 2013, May-13, Volume: 7, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli Infections; Humans; Latin America; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Uropathogenic Escherichia coli	2013
Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope. The Journal of hospital infection, 2013, Volume: 85, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; Disinfection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genes, Bacterial; Genotype; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Sequence Analysis, DNA; Taiwan; Ureteroscopes; Urinary Tract Infections	2013
Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Empirical Research; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Risk; Tetracycline; Urinary Tract Infections	2013
Visual hallucinations related to use of ertapenem. Neurologia (Barcelona, Spain), 2015, Volume: 30, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Hallucinations; Humans; Male; Urinary Tract Infections	2015
Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chromatography, Liquid; Ertapenem; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Statistical; Outpatients; Prospective Studies; Serum; Tandem Mass Spectrometry; Urinary Tract Infections; Urine; Young Adult	2014
Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program. BMC infectious diseases, 2014, Sep-05, Volume: 14 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Longitudinal Studies; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus Infections; Proteus mirabilis; Taiwan; Urinary Tract Infections; Young Adult	2014
Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Costs and Cost Analysis; Ertapenem; Escherichia coli; Female; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult	2016
Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran. BioMed research international, 2015, Volume: 2015 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Iran; Male; Urinary Tract Infections	2015
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections	2016
Ertapenem-induced acute reversible peripheral neuropathy in chronic kidney disease: 3 case reports. Clinical nephrology, 2015, Volume: 84, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Diabetes Mellitus, Type 2; Electroencephalography; Electromyography; Enterococcus faecalis; Ertapenem; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Renal Insufficiency, Chronic; Risk Factors; Urinary Tract Infections	2015
Potentialization of β-lactams with colistin: in case of extended spectrum β-lactamase producing Escherichia coli strains isolated from children with urinary infections. Research in microbiology, 2016, Volume: 167, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Colistin; DNA, Bacterial; Drug Synergism; Escherichia coli; Escherichia coli Infections; France; Hospitals; Humans; Microbial Sensitivity Tests; Microbial Viability; Molecular Typing; Plasmids; Random Amplified Polymorphic DNA Technique; Urinary Tract Infections	2016
A Case of Sepsis in a 92-Year-Old Korean Woman Caused by Aerococcus urinae and Identified by Sequencing the 16S Ribosomal RNA Gene. Laboratory medicine, 2016, Volume: 47, Issue:2 Topics: Aerococcus; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Meropenem; Remission Induction; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, RNA; Thienamycins; Urinary Tract Infections	2016
Predictors of ertapenem therapeutic efficacy in the treatment of urinary tract infections (UTIs) in hospitalized adults: the importance of renal insufficiency and urinary pH. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016, Volume: 35, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Urine; Young Adult	2016
Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections. International journal of antimicrobial agents, 2016, Volume: 48, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Male; Middle Aged; Outpatients; Patient Readmission; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult	2016
Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections. Journal of chemotherapy (Florence, Italy), 2017, Volume: 29, Issue:1 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Humans; Male; Middle Aged; Prospective Studies; Urinary Tract Infections; Young Adult	2017
[Adequacy of treatment with ertapenem according to the criterion approved for the infection´s commission of a specialty hospital]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Ertapenem; Female; Guideline Adherence; Hospitals; Humans; Inappropriate Prescribing; Internal Medicine; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult	2016
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam? Expert review of anti-infective therapy, 2016, Volume: 14, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Penicillanic Acid; Pseudomonas Infections; Tazobactam; Urinary Tract Infections	2016
Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Tr The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:1 Topics: Anti-Bacterial Agents; Asia; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Pacific Islands; Urinary Tract Infections	2017
Comparison of quinolone and beta-lactam resistance among Escherichia coli strains isolated from urinary tract infections. Le infezioni in medicina, 2016, 12-01, Volume: 24, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Hospitals; Humans; Inpatients; Iran; Microbial Sensitivity Tests; Outpatients; Prevalence; Quinolones; Urinary Tract Infections	2016
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. Journal of medical microbiology, 2017, Volume: 66, Issue:1 Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections	2017
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections. The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections	2017
Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia. Annals of the Academy of Medicine, Singapore, 2008, Volume: 37, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Urinary Tract Infections	2008
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections	2009
Evidence for qnrB1 and aac(6')-Ib-cr in CTX-M-15-producing uropathogenic Enterobacteriaceae in an Italian teaching hospital. Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Order; Genes, Bacterial; Hospitals, Teaching; Humans; Italy; Urinary Tract Infections	2009
[Efficacy and safety of faropenem in pediatric patients with bacterial infectious diseases]. The Japanese journal of antibiotics, 2008, Volume: 61, Issue:6 Topics: beta-Lactams; Child; Child, Preschool; Dosage Forms; Drug Resistance, Bacterial; Humans; Otitis Media; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Treatment Outcome; Urinary Tract Infections	2008
[Microbiol landscape and production of beta-lactamases with extended spectrum activity in patients with urinary tract infection]. Klinicheskaia meditsina, 2009, Volume: 87, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Colony Count, Microbial; Gram-Negative Bacteria; Humans; Retrospective Studies; Urinary Tract Infections	2009
Urinary tract infections. Roundtable discussion and case studies. Postgraduate medicine, 2000, Volume: 108, Issue:7 Suppl Pr Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Diagnosis, Differential; Female; Fluoroquinolones; Humans; Male; Middle Aged; Postmenopause; Premenopause; Sexually Transmitted Diseases; Urinary Tract Infections	2000
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010, Volume: 14 Suppl 3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Spinal Diseases; Treatment Failure; Urinary Tract Infections	2010
Extended-spectrum beta-lactamase-producing bacteria and vesicoureteral reflux in children. Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli Infections; Humans; Infant; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Pyelonephritis; Recurrence; Urinary Tract Infections; Vesico-Ureteral Reflux	2010
Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008. Diagnostic microbiology and infectious disease, 2010, Volume: 67, Issue:1 Topics: Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Ertapenem; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Humans; Nitrofurantoin; Prevalence; Urinary Tract Infections; Urine; Uropathogenic Escherichia coli	2010
CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:2 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Community-Acquired Infections; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Hospitals, University; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Turkey; Urinary Tract Infections	2010
Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:7 Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Health Care Costs; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United Kingdom; Urinary Tract Infections	2010
Klebsiella pneumoniae ESBL producers responsible for severe UTIs in a renal transplant unit. Infection, 2011, Volume: 39, Issue:1 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Urinary Tract Infections	2011
Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children. Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Follow-Up Studies; Hospitals; Humans; Infant; Male; Pyelonephritis; Recurrence; Retrospective Studies; Turkey; Urinary Tract Infections	2011
Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactams; Catheter-Related Infections; Conjugation, Genetic; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Gene Expression Profiling; Gene Transfer, Horizontal; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Molecular Weight; Mutation; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Selection, Genetic; Thienamycins; Urinary Tract Infections; Urine	2012
[Clinical and economic expedience of ertapenem therapy of complicated urinary tract infection]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:1-2 Topics: Anti-Bacterial Agents; beta-Lactams; Costs and Cost Analysis; Drug Resistance, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Humans; Male; Russia; Urinary Tract Infections	2011
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections	2012
Development of carbapenem resistance during therapy for non-typhoid Salmonella infection. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:4 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Feces; Female; Humans; Microbial Sensitivity Tests; Plasmids; Point Mutation; Porins; RNA, Bacterial; Salmonella Infections; Salmonella typhimurium; Urinary Tract Infections; Wound Infection	2012
Risk factors for urinary tract infection caused by Enterobacteriaceae with extended-spectrum beta-lactamase resistance in patients admitted to internal medicine departments. The Israel Medical Association journal : IMAJ, 2012, Volume: 14, Issue:2 Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cohort Studies; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Internal Medicine; Israel; Male; Odds Ratio; Prevalence; Retrospective Studies; Risk Factors; Urinary Tract Infections	2012
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). International journal of antimicrobial agents, 2012, Volume: 40 Suppl Topics: Amikacin; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies; Urinary Tract Infections	2012
[Urinary tract infections due to wide spectrum beta lactamase producing enterobacteriaceae]. Presse medicale (Paris, France : 1983), 2002, Aug-10, Volume: 31, Issue:26 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Geriatrics; Hospital Departments; Humans; Length of Stay; Male; Recurrence; Survival Rate; Treatment Failure; Urinary Tract Infections	2002
Nosocomial infections caused by multidrug-resistant isolates of pseudomonas putida producing VIM-1 metallo-beta-lactamase. Journal of clinical microbiology, 2002, Volume: 40, Issue:11 Topics: Aged; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Integrons; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Pseudomonas Infections; Pseudomonas putida; Urinary Tract Infections	2002
[Evaluation of sensitivity to antibiotics of microorganisms isolated from children with urinary tract infections]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2003, Volume: 14, Issue:82 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; beta-Lactams; Child; Female; Humans; Male; Microbial Sensitivity Tests; Urinary Tract Infections	2003
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France]. Pathologie-biologie, 2004, Volume: 52, Issue:2 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections	2004
In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Genes, Bacterial; Humans; Lactams; Microbial Sensitivity Tests; Urinary Tract Infections	2004
[Analysis of anti-microbial resistance of Escherichia coli that caused infection in urogenital system]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2004, Volume: 24, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Quinolones; Urinary Tract Infections	2004
Management of urinary tract infections: historical perspective and current strategies: Part 2--Modern management. The Journal of urology, 2005, Volume: 173, Issue:1 Topics: Anti-Infective Agents, Urinary; beta-Lactams; Fluoroquinolones; Humans; Nitrofurantoin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinalysis; Urinary Tract Infections	2005
Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting. Journal of clinical microbiology, 2005, Volume: 43, Issue:10 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Risk Factors; Urinary Tract Infections	2005
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:4 Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Risk Factors; Urinary Tract Infections	2006
History of cerebrovascular events: a relative contraindication to ertapenem treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jul-15, Volume: 43, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Male; Seizures; Stroke; Urinary Tract Infections	2006
Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections. International journal of antimicrobial agents, 2006, Volume: 28 Suppl 1 Topics: Anti-Infective Agents; beta-Lactams; Fluoroquinolones; Fosfomycin; Humans; Nitrofurantoin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2006
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Chest, 2006, Volume: 130, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical	2006
Efficacy of short-term intravenous antibiotic in neonates with urinary tract infection. Pediatric emergency care, 2007, Volume: 23, Issue:2 Topics: Acute Disease; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Emergency Service, Hospital; Female; Follow-Up Studies; Gentamicins; Humans; Infant, Newborn; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Assessment; Treatment Outcome; Urinalysis; Urinary Tract Infections	2007
Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli? The Journal of hospital infection, 2008, Volume: 68, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Hong Kong; Humans; Retrospective Studies; Treatment Outcome; Urinary Tract Infections	2008
Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality. The Journal of hospital infection, 2008, Volume: 68, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Case-Control Studies; Cohort Studies; Escherichia coli; Escherichia coli Infections; Female; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Spain; Treatment Outcome; Urinary Tract Infections	2008
Genetic analysis of faropenem-resistant Enterococcus faecalis in urinary isolates. The Journal of antibiotics, 2008, Volume: 61, Issue:4 Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Genotype; Humans; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Urinary Tract Infections	2008
In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer. Bollettino dell'Istituto sieroterapico milanese, 1984, Volume: 63, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Urinary Tract Infections	1984
Relevance of in vitro antibacterial activities and pharmacokinetic properties of antipseudomonal beta-lactam antibiotics to their therapeutic effects on urinary tract infection caused by Pseudomonas aeruginosa P 9 in mice. The Journal of antibiotics, 1984, Volume: 37, Issue:3 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Female; Kidney; Kinetics; Mice; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections	1984
Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria. The Journal of antimicrobial chemotherapy, 1981, Volume: 7, Issue:3 Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Drug Combinations; Female; Humans; Male; Middle Aged; Penicillin Resistance; Urinary Tract Infections	1981
[Treatment with amoxicillin and clavulanic acid of urinary tract infections in patients with spinal injuries]. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1982, Jul-28, Volume: 62, Issue:5 Spec No Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Combinations; Enzyme Inhibitors; Humans; Spinal Injuries; Urinary Tract Infections	1982
[Clinical significance of bacterial beta-lactamase production in the treatment of urinary tract infections with oral beta-lactam-antibiotics]. Der Urologe. Ausg. A, 1982, Volume: 21, Issue:4 Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Female; Humans; Male; Urinary Tract Infections	1982
[Importance and administration of beta-lactam antibiotics in practice]. Die Medizinische Welt, 1982, Aug-13, Volume: 33, Issue:31-32 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ear Diseases; Humans; Pharyngitis; Pneumonia, Pneumococcal; Urinary Tract Infections	1982
[Significant role of penem antibiotics: focused on faropenem (discussion)]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:7 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Lactams; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections	1997
Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacteria; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple; Fluoroquinolones; Hospitalization; Humans; Latin America; Microbial Sensitivity Tests; Molecular Epidemiology; Urinary Tract Infections	2000
Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:1 Topics: Animals; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Dog Diseases; Dogs; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli Infections; Microbial Sensitivity Tests; Portugal; Urinary Tract Infections	2002
Ertapenem (Invanz)--a new parenteral carbapenem. The Medical letter on drugs and therapeutics, 2002, Mar-18, Volume: 44, Issue:1126 Topics: Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Ertapenem; Gram-Negative Bacterial Infections; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Lactams; Pneumonia; Urinary Tract Infections	2002
Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections. The Journal of antimicrobial chemotherapy, 1979, Volume: 5, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clavulanic Acid; Escherichia coli; Female; Humans; Middle Aged; Proteus mirabilis; Urinary Tract Infections	1979
Colonial morphology of staphylococci on Memphis agar: phase variation of slime production, resistance to beta-lactam antibiotics, and virulence. The Journal of infectious diseases, 1990, Volume: 161, Issue:6 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Culture Media; Disease Models, Animal; Drug Resistance, Microbial; Endocarditis, Bacterial; Male; Mice; Microscopy, Electron; Mutation; Phagocytosis; Phenotype; Rats; Rats, Inbred Strains; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Urinary Tract Infections; Virulence	1990
[Urinary tract infection in gynecology-obstetrics: resistance to beta-lactam antibiotics and previous antibiotic therapy]. Pathologie-biologie, 1990, Volume: 38, Issue:5 ( Pt 2) Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Female; Genital Diseases, Female; Humans; Obstetrics and Gynecology Department, Hospital; Pregnancy; Pregnancy Complications, Infectious; Urinary Tract Infections	1990
Antibacterial activity of six beta-lactams and six quinolones against urinary gram negative bacteria. Bollettino dell'Istituto sieroterapico milanese, 1986, Volume: 65, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Urinary Tract Infections	1986
[Beta-lactam antibiotic sensitivity of Gram-negative bacteria isolated from urology patients]. Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology, 1985, Volume: 30, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactams; Gram-Negative Aerobic Bacteria; Humans; Microbial Sensitivity Tests; Nephritis; Urinary Tract Infections	1985
Activity of FL 1060, a new beta-lactam antibiotic, against urinary tract pathogens. Journal of clinical pathology, 1974, Volume: 27, Issue:3 Topics: Ampicillin; Anti-Infective Agents, Urinary; Bacteriological Techniques; beta-Lactams; Enterobacteriaceae; Escherichia coli; Humans; Microbial Sensitivity Tests; Osmolar Concentration; Penicillin Resistance; Phenotype; Streptococcus; Time Factors; Urinary Tract Infections	1974